You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information |
---|
Version | 4.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2020-02-26 21:40:00 UTC |
---|
HMDB ID | HMDB0014623 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Lenalidomide |
---|
Description | Lenalidomide, also known as revlimid or IMID3, belongs to the class of organic compounds known as isoindolones. These are aromatic polycyclic compounds that an isoindole bearing a ketone. Lenalidomide is a drug. Lenalidomide is a moderately basic compound (based on its pKa). A dicarboximide that consists of 1-oxoisoindoline bearing an amino substituent at position 4 and a 2,6-dioxopiperidin-3-yl group at position 2. |
---|
Structure | |
---|
Synonyms | Value | Source |
---|
1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline | ChEBI | 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione | ChEBI | Revlimid | ChEBI | CC-5013 | HMDB | CDC 501 | HMDB | IMiD3 | HMDB | Revimid | HMDB | Celgene brand OF lenalidomide | HMDB | IMiD3 CPD | HMDB |
|
---|
Chemical Formula | C13H13N3O3 |
---|
Average Molecular Weight | 259.2606 |
---|
Monoisotopic Molecular Weight | 259.095691297 |
---|
IUPAC Name | 3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione |
---|
Traditional Name | lenalidomide |
---|
CAS Registry Number | 191732-72-6 |
---|
SMILES | NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O |
---|
InChI Identifier | InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) |
---|
InChI Key | GOTYRUGSSMKFNF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as isoindolones. These are aromatic polycyclic compounds that an isoindole bearing a ketone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Isoindoles and derivatives |
---|
Sub Class | Isoindolines |
---|
Direct Parent | Isoindolones |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid or derivatives
- Isoindolone
- Isoindole
- Piperidinedione
- Delta-lactam
- Piperidinone
- Piperidine
- Benzenoid
- Carboxylic acid imide
- Dicarboximide
- Carboxylic acid imide, n-unsubstituted
- Tertiary carboxylic acid amide
- Amino acid or derivatives
- Lactam
- Carboxamide group
- Carboxylic acid derivative
- Azacycle
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Hydrocarbon derivative
- Primary amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
|
Disposition | Biological location: |
---|
Role | Industrial application: |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 2.33 g/L | Not Available | LogP | -0.4 | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
| Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-01si-4950000000-d56c036a1d29e5a9442f | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - LC-ESI-qTof , Positive | splash10-0002-1920000000-c10c48acd9b8123e3505 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - , positive | splash10-0002-1920000000-c10c48acd9b8123e3505 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03dl-0090000000-2431a4e4063fb866e502 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03dl-0590000000-3bd8341d78d9f0bb2185 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0006-5900000000-ede52ce7143fcbe39e3c | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0190000000-a51e8a05d578a97d3916 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0btc-2980000000-9fa6887f8d1dd5044b78 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-000f-9500000000-60ff64f6a1048a417538 | Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00480 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00480 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00480 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 187515 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Lenalidomide |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 216326 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 63791 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, Rimsza L, Heaton R, Knight R, Zeldis JB: Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med. 2005 Feb 10;352(6):549-57. [PubMed:15703420 ]
- Anderson KC: Lenalidomide and thalidomide: mechanisms of action--similarities and differences. Semin Hematol. 2005 Oct;42(4 Suppl 4):S3-8. [PubMed:16344099 ]
- Chang DH, Liu N, Klimek V, Hassoun H, Mazumder A, Nimer SD, Jagannath S, Dhodapkar MV: Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications. Blood. 2006 Jul 15;108(2):618-21. Epub 2006 Mar 28. [PubMed:16569772 ]
|
---|